Author: Papi P, Letizia C, Pilloni A, Petramala L, Saracino V, Rosella D, Pompa G.
Source: European Review for Medical and Pharmacological Sciences.
Year: 2018
Comment:
Abstract / Excerpt:
OBJECTIVE:
Metabolic syndrome (MetS) is defined as a spectrum of conditions associated with an increased risk of developing CVD and type 2 diabetes. MetS include: hyperglycemia, hypertension, visceral obesity, dyslipidemia with elevated values of triglycerides (TG) and low levels of HDL. The aim of this review is to provide current knowledge of the relationship between MetS, its components and peri-implant diseases.
MATERIALS AND METHODS:
An electronic literature search was conducted in the English language in several databases. The Newcastle-Ottawa Scale was used for quality assessment of cohort and cross-sectional studies; while systematic reviews were evaluated through AMSTAR; results were reported according to the PRISMA Statement.
RESULTS:
A total of 272 records were identified through database searching, six studies were included for qualitative analysis. No study directly related to MetS was found, there was inconsistent and controversial evidence regarding association with cardiovascular disease. A higher risk of peri-implantitis was detected in people with hyperglycemia.
CONCLUSIONS:
Future research should be orientated in assessing the risk of peri-implant diseases, evaluating patient’s therapeutic response, analyzing directionality of the relationship between MetS, its components and biologic implant complications.
Citation: Papi P, Letizia C, Pilloni A, Petramala L, Saracino V, Rosella D, Pompa G. Peri-implant diseases and metabolic syndrome components: a systematic review. European Review for Medical and Pharmacological Sciences. 2018;22:866-75.